Agilent Life Sciences SSEL Cancer CGP Assay Probes DNA+RNA, 96
The Agilent SureSelect Cancer CGP Assay Probes DNA+RNA, 96 (part number 5191-6991) is designed for comprehensive genomic profiling (CGP) of cancer samples. This product enables the simultaneous analysis of DNA and RNA from a single sample, supporting the detection of a wide range of genomic alterations including single nucleotide variants (SNVs), insertions/deletions (indels), copy number variations (CNVs), and gene fusions. The kit is optimized for high-throughput workflows and is compatible with next-generation sequencing (NGS) platforms, providing robust performance for clinical research and translational oncology applications.